share_log

Haoxi Health Technology 2H 2023 EPS $0.03 Vs $0.02 YoY; Revenue $23.5M Vs $9.16M YoY

Benzinga ·  May 31 08:06

Financial Highlights for the Six Months Ended December 31, 2023

  • Total revenue for the six months ended December 31, 2023 was US$23.50 million, increased by US$14.34 million, or 157%, from US$9.16 million for the same period in 2022.
  • Gross profit for the six months ended December 31, 2023 was US$1.20 million, representing an increase of 65% from US$0.73 million for the same period in 2022.
  • Net income for the six months ended December 31, 2023 was US$0.76 million, increasing by US$0.31 million, or 70%, from US$0.45 million for the six months ended December 31, 2022.

Mr. Zhen Fan, Chairman and Chief Executive Officer of the Company, stated that, "We are pleased to record an increase in revenue of 157% to US$23.50 million, and in gross profit of 65% to US$1.20 million during the first six months ended December 31, 2023. The growth we achieved during this period underscores our commitment to providing innovative and effective online marketing solutions. Looking ahead, we remain committed to leveraging the power of popular media platforms in China to drive success for our advertiser clients and deliver sustainable value to our shareholders. With our experience in the online marketing industry, we believe HAO is prepared to enhance its financial performance in the future."

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment